一般消費者向け遺伝子検査の米23andMe（トゥエンティースリー・アンド・ミー）社が2025年3月、破産手続きに入ったことをめぐり、同社を米Regeneron ...

Regeneron agreed to acquire 23andMe for $256 million. At its peak, 23andMe's market value swelled to $5.8 billion. Recently, ...

Regeneron Pharmaceuticals has announced that it will be acquiring human genetics and biotechnology company 23andMe for $256m.

経営破綻した米遺伝子検査サービス企業、23andMe（トゥウェンティー・スリー・アンド・ミー）は、約1500万人のＤＮＡサンプルを含むデータベースをバイオ医薬品メーカーのリジェネロン・ファーマシューティカルズに２億5600万ドル（約370億円）で売却 ...

Regeneron will acquire 23andMe’s core assets for $256 million, ensuring customer data privacy and continuing the mission of ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

Regeneron acquires 23andMe's genetics services for (Dollar) 256 million * Customer privacy safeguards will remain in place ...

Regeneron Pharmaceuticals, a biotechnology company with a long history of large-scale genetics research, plans to buy DNA testing firm 23andMe out of bankruptcy, announcing Monday it was named the ...

Genetic information submitted by millions of 23andMe users is now in the hands of pharmaceutical giant Regeneron, following a ...

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a ...